<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Sweden Herald - Lars Lannfeldt]]></title>
        <description><![CDATA[The latest Sweden Herald stories about Lars Lannfeldt, in English.]]></description>
        <link>https://swedenherald.com/people/lars-lannfeldt</link>
        <generator>RSS for Node and Next.js</generator>
        <lastBuildDate>Thu, 05 Nov 2026 06:07:33 GMT</lastBuildDate>
        <atom:link href="https://swedenherald.com/rss/people/lars-lannfeldt.xml" rel="self" type="application/rss+xml"/>
        <copyright><![CDATA[Sweden Herald]]></copyright>
        <language><![CDATA[en-US]]></language>
        <ttl>60</ttl>
        <item>
            <title><![CDATA[Medicine Stop a Hard Blow for Alzheimer's Patients]]></title>
            <description><![CDATA[The disappointment is great since a new drug against Alzheimer's has been rejected by the EU's pharmaceutical authority. It is outrageous, says Liselotte Jansson at the Alzheimer's Foundation.]]></description>
            <link>https://swedenherald.com/article/medicine-stop-a-hard-blow-for-alzheimers-patients</link>
            <guid isPermaLink="true">https://swedenherald.com/article/medicine-stop-a-hard-blow-for-alzheimers-patients</guid>
            <category><![CDATA[Sweden News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Wed, 31 Jul 2024 03:30:28 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/fd8af7a3-2612-46a5-a315-ba7c2025ec44/fd8af7a3-2612-46a5-a315-ba7c2025ec44.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/fd8af7a3-2612-46a5-a315-ba7c2025ec44/fd8af7a3-2612-46a5-a315-ba7c2025ec44.jpg" medium="image" type="image/jpeg" width="1024" height="683"/>
        </item>
        <item>
            <title><![CDATA[Alzheimer's drug rejected by EMA]]></title>
            <description><![CDATA[The Alzheimer's drug lecanemab has not been approved by the European Medicines Agency EMA. The benefits are not considered to outweigh the potential drawbacks. A review of the decision will be requested, announces Swedish Bioarctic – whose share plummeted on the news.]]></description>
            <link>https://swedenherald.com/article/alzheimers-drug-rejected-by-ema</link>
            <guid isPermaLink="true">https://swedenherald.com/article/alzheimers-drug-rejected-by-ema</guid>
            <category><![CDATA[Sweden News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Fri, 26 Jul 2024 12:26:48 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/4a4205e3-ca46-4258-b19a-75219160f11f/4a4205e3-ca46-4258-b19a-75219160f11f.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/4a4205e3-ca46-4258-b19a-75219160f11f/4a4205e3-ca46-4258-b19a-75219160f11f.jpg" medium="image" type="image/jpeg" width="1024" height="699"/>
        </item>
    </channel>
</rss>